The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1695-1701

  Pajkos, Gábor ^a,d   Kiss, István ^b   Sándor, János ^b   Ember, István ^b   Kisházi, Péter ^c  

^a MI Central Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c St Margit Hospital   (Hungary)

^d 2nd Dept Internal Medicine Oncology   (Hungary)

Author keywords

Colorectal cancer; K ras oncogene; MASA ; PCR method

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CODON; COLON ADENOCARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; SURVIVAL TIME;

CODON; COLORECTAL NEOPLASMS; FEMALE; GENES, RAS; GENETIC MARKERS; HUMANS; MALE; MUTATION; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033868043     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Demographic yearbook pp. 39-45. KSH, Budapest, 1996.
2. Jessup JM, McGinnis LS, Steele GD, Menck HR, Winchester DP: The National Cancer Database Report on Colon Cancer. Cancer 78: 918-926, 1996.
3. Levi F, La Vecchia C, Lucchini F and Negri E: Cancer mortality in Europe 1990-92. Eur J Cancer Prev 5: 389-417, 1995.
4. Bruce WR: Recent hypotheses for the origin of colon cancer. Cancer Res 47: 4237-4242, 1987.
5. Vogelstein B, Fearon E R, Hamilton SR et al: Genetic alterations during colorectal-tumour development. N Engl J Med 319: 525-532, 1988.
6. Bodmer WF, Bailey C, Bodmer J et al.: Localisation of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614-616, 1987.
7. Lindhlom A, Tannergard P, Werelius B, and Nordenskjold M: Genetic mapping of a second locus predisposing to hereditary non-polyposis colorectal cancer. Nat Genet 5: 279-282, 1993.
8. Finkelstein SD, Sayegh R, Christensen S et al: Genotype classification of colorectal adenocarcinoma. Cancer 71: 3827-3838, 1993.
9. Bos JL: ras oncogene in human cancer: A review. Cancer Res 49: 4682-4689, 1989.
10. Fearon ER, Hamilton SR, Vogelstein B: Clonal analysis of human colorectal tumours. Science 238: 193-196, 1987.
11. Cunningham C, Dunlop MG: Genetics of colorectal cancer. Br Med Bull 50: 640-655, 1994.
12. Dix BR, Robbins P, Soong R et al: The common molecular genetic alterations in Dukes'B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 59: 747-751, 1994.
13. Ichii S, Takeda S, Horii A, et al: Detailed analysis of genetic alterations in colorectal tumours from patients with and without familial adenomatous polyposis (FAP) Oncogene 8: 2399-2404, 1993.
14. Bailar JC III, Mosteller F (eds.): Medical Uses of Statistics. Waltham, Massachusetts, NEJM Books, 1986.
15. 2 (RAS) mutation in patients with advanced colorectal cancer treated with 5-fluorouracil (5-FU) and interferon (IFN): an Eastern Oncology Group (ECOG) study. Proc Am Soc Clin Oncol 15: 210, 1996.
16. Breivik J, Meling GI, Spurklan A et al: K-ras mutation in colorectal cancer. Relations to patient age, sex and tumour location. Br J Cancer 69: 367-371, 1994.
17. Oliani C, Giaretti W, Pujic N et al: DNA content and K-ras2 mutations in colorectal cancer. Proc Am Soc Clin Oncol 14: 212, 1995.
18. Tanaka M, Omura K, Watanahe Y et al: Prognostic factors of colorectal cancer: K-ras mutation, overexpression of the p53 protein. and cell proliferate activity. J Surg Oncol 57: 57-64, 1995.
19. Thomas G: Advances in the genetics and molecular biology of colorectal tumours. Cur Opin Oncol 6: 406-412, 1995.
20. Trock B, Lanza E, Greenwald P: Dietary fibre, vegetables, and colon cancer: Critical review and metaanalysis of the epidemiological evidence. J Natl Cancer Inst 82: 650-661, 1995.
21. Kato M, Ito Y, Kobayashi S et al: Deletion of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence. Cancer 77: 1729-1735, 1995.
22. McMichael AJ, Potter JD: Host factors in carcinogenesis: Certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 75: 185-191, 1995.
23. Wait R, Thompson MH, Hill MJ: Faecal steroids and colorectal cancer: Allo bile acids. Br J Cancer 52: 445-456, 1995.